Skip to main content

Table 1 Baseline participants characteristicsa

From: Bedside POCUS during ward emergencies is associated with improved diagnosis and outcome: an observational, prospective, controlled study

Variables

Control group n = 82

POCUS group n = 83

P value

Men

48 (59)

55 (66)

0.31

Age, median [IQR] years

67 [57–77]

70 [59–81]

0.49

Indication for placing the call to the RRTs

   

Respiratory

56 (68)

61 (74)

0.46

Circulatory

26 (32)

22 (26)

 

Indication for hospital admission

   

Cardiac

10 (12)

3 (4)

0.27

Respiratory

30 (37)

23 (28)

 

Neurologic

2 (2)

7 (9)

 

Digestive

8 (10)

8 (10)

 

Obstetrical

1 (1,5)

0

 

Infectious

2 (2,5)

2 (2)

 

General

4 (5)

4 (5)

 

Surgery

24 (29)

28 (34)

 

Urologic

0

2 (2)

 

Vascular

1 (1)

3 (4)

 

Traumatic

0

3 (4)

 

BMI (> 25), kg/m2

   
 

41 (50)

39 (47)

0.70

ASA score

   

I-II

23 (28)

23 (28)

0.99

III

47 (57)

48 (58)

 

IV–V

12 (15)

12 (14)

 

SAPS IIb, median [IQR]

   
 

46 [34–57]

40 [33–52]

0.51

Comorbidities

   

Allergy

9 (11)

8 (10)

0.78

Coronary disease

22 (27)

23 (28)

0.89

Heart failure

19 (23)

27 (32)

0.18

Chronic kidney disease

11 (13)

19 (22)

0.16

Cancer

28 (34)

26 (31)

0.70

Immunodepression

10 (12)

13 (15)

0.52

Dementia

5 (6)

3 (4)

0.49

Stroke

8 (9,8)

9 (11)

0.82

Epilepsy

5 (6)

1 (1)

0.12

Diabetes

13 (16)

21 (25)

0.13

Liver disease

6 (7)

6 (7)

0.98

COPD

36 (44)

30 (36)

0.31

Habitual smoker

42 (51)

34 (41)

0.19

Definitive diagnosisc

   

Exacerbation of asthma

3 (5)

3 (5)

0.60

Septic shock

14 (17)

 

14 (17)

Pneumonia

18 (22)

7 (8)

 

Cardiogenic edema

10 (12)

13 (16)

 

Hemorrhagic shock

7 (8)

4 (5)

 

Atelectasis

1 (1)

4 (5)

 

Exacerbation of COPD

5 (6)

6 (7)

 

Pneumothorax

1 (1)

1 (1)

 

Pleural effusion

3 (5)

4 (5)

 

Acute interstitial lung disease (non-cardiogenic edema)

4 (5)

7 (8)

 

Pulmonary embolism

2 (2)

2 (2)

 

Cardiogenic shock

2 (2)

2 (2)

 

Hypovolemic shock

1 (1)

1 (1)

 

Tamponade

1 (1)

2 (2)

 

Exacerbation of COPD/cardiogenic edema

0

1 (1)

 

Pneumonia/cardiogenic edema

0

1 (1)

 

Pneumonia/acute interstitial lung disease (non-cardiogenic edema)

1 (1)

3 (5)

 

Exacerbation of COPD/pneumothorax

2 (2)

0

 

Normal

0

2 (2)

 

Other†

7 (9)

6 (8)

 

Urine volume 24 h before inclusion (ml/day)

   

 < 200

6 (7)

4 (5)

0.58

 < 500

29 (35)

24 (29)

 

 > 500

37 (45)

40 (48)

 

 > 1000

10 (12)

15 (18)

 

Mottlingd

22 (27)

10 (12)

0.02

Respiratory distress syndrome

49 (60)

54 (65)

0.48

Abnormal chest auscultatione

62 (76)

59 (71)

0.51

Thorax X-ray < 24 h

35 (42)

38 (46)

0.69

MAP, median [IQR], mmHg

82 [70–100]

93 [72–113]

0.02

Heart rate, median [IQR], bpm*

100 [80–120]

107 [85–130]

0.46

Serum lactate median [IQR], mmol/l

2 [1–3]

2 [1–3]

0.95

Hemoglobin, median [IQR], g/dl

11 [9–13]

11 [9–12]

0.18

Serum creatinine, median [IQR],mmol/L

79 [52–125]

82 [62 -132]

0.51

Total bilirubin, median [IQR] umol/l

10 [8–16]

10 [8–16]

0.91

Serum potassium, median [IQR], mmol/L

4 [4, 5]

4 [4, 5]

0.41

Volemic expansion at the bedside, median [IQR], ml/kg

3 [0–10]

4 [0 -12]

0.73

Respiratory rate, median [IQR] bpm**

27 [20–35]

25 [20–35]

0.51

SpO2, median [IQR], %

92 [89–96]

94 [90–97]

0.16

PaO2/FiO2 ratio, median [IQR]

186 [121–284]

203 [136–355]

0.28

Glasgow score, median [IQR]

15 [2–15]

15 [14, 15]

0.08

BNP, median [IQR] pg/ml

306 [129–584]

188 [62–833]

0.61

Oxygen rate flow, median [IQR], L/min

12 [5–15]

6 [2–15]

0.003

Orientation after inclusion

   

Immediate ICU

59 (72)

49 (55)

0.15

Operative room

5 (6)

7 (8)

 

Emergency room

4 (5)

9 (12)

 

Ward

14 (17)

21 (25)

 
  1. BMI, body mass index; ASA, Score of American Society of Anesthesiologists; SAPS II, Simplified Acute Physiology Score II; COPD, chronic obstructive pulmonary disease; MAP, median arterial pressure; SpO2, pulse oximetry; PaO2/FiO2 ratio, ratio of arterial oxygen partial to fractional inspired oxygen; BNP, brain natriuretic peptide; bpm*: beats per minute; bpm**: breaths per minute; IQR, interquartile range; RRT, rapid response team
  2. aData are expressed as No (%) of participants unless otherwise indicated. At the bedside
  3. bThe SAPS II ranges from 0 to 163, with higher scores indicating higher risk of mortality. A patient with a score of 40 has an estimated mortality risk of 30%
  4. cDiagnosis established after medical files and supplementary workup
  5. dOnly presence or absence of mottlings
  6. eAbnormal was defined like pathological auscultation
  7. †Panic attack (1), anaphylaxia (2), bronchospasm (1), hemoptysis (1), intraalveolar hemorrhage (1), laryngeal dyspnea (1), morphine surdosage (1), pulmonary hypertension crisis (1), tracheal decannulation (1), neurological failure (1) and valve thrombosis (1)